サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1362925

ヒアルロン酸原材料の市場規模、シェア、動向分析レポート：用途別、原料別、グレード別、地域別、セグメント予測、2023-2030年

Hyaluronic Acid Raw Material Market Size, Share & Trends Analysis Report By Application (Ophthalmology, Orthopedics), By Source (Non-Animal, Animal), By Grade, By Region, And Segment Forecasts, 2023 - 2030

出版日
ページ情報
英文 120 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.96円
ヒアルロン酸原材料の市場規模、シェア、動向分析レポート：用途別、原料別、グレード別、地域別、セグメント予測、2023-2030年
出版日: 2023年09月07日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ヒアルロン酸原材料市場の成長と動向：

Grand View Research, Inc.の新しいレポートによると、世界のヒアルロン酸原材料市場規模は2030年までに108億米ドルに達する見込みです。

市場は2023年から2030年までCAGR 6.5%で拡大する見込みです。変形性関節症、創傷治癒、術後癒着、鼓膜修復、腫瘍診断、骨折治癒、軟部組織修復などの様々な医療用途でヒアルロン酸の使用が増加していることが、予測期間中の市場成長を促進すると見られています。

整形外科セグメントは、2015年に市場全体を支配し、最も高い収益を上げています。老人人口の増加、変形性関節症の罹患率の上昇、治療におけるビスコサプリメントの採用拡大が、このセグメントの大きな市場シェアに寄与しています。さらに、ドラッグデリバリー分野はCAGRが著しく高く、予測期間中に最も急成長すると予測されています。標的ドラッグデリバリーシステムに焦点を当てた研究開発活動の増加と、抗がん剤デリバリーにおけるヒアルロン酸の使用量の増加が、市場成長に寄与すると予想されます。

世界中で35歳から65歳の女性人口が増加しているため、アンチエイジングのための化粧品や美容治療に対する需要が高まっています。ヒアルロン酸ベースの製品によって提供される低毒性レベルと結合した独特の粘弾性と保湿特性のおかげで、皮膚フィラーや膀胱尿管逆流症の治療におけるこのポリマーの需要は成長が期待されます。このように、このような製品に対するニーズは、予測期間中、ヒアルロン酸製品にとってインパクトのある原動力になると予想されます。2014年の国際美容整形外科学会の統計によると、世界中で約2,000万件の美容整形手術が行われ、そのうち約13.5%がHAを使った非外科的手術でした。

2014年に美容施術の大半を記録した上位の国々は、米国、ブラジル、日本、韓国、メキシコ、ドイツ、フランス、コロンビアでした。米国における美容整形を目的とした医療ツーリズムは、HAをベースとした製品や施術の普及を助ける上で非常に重要な役割を果たしており、今後数年間は市場を牽引すると予想されます。

ヒアルロン酸原材料市場レポートハイライト：

  • 整形外科分野は、変形性関節症の治療処置におけるヒアルロン酸の幅広い使用と相まって、技術的に進歩した薬剤の採用が増加しているため、2022年には39.7%の最大の売上シェアで市場を独占しました。
  • ORTHOVISCやMONOVISCのようなFDA承認のヒアルロン酸ベースのビスコサプリメントのイントロダクションは、今後8年間の使用量を押し上げると予想されています。
  • 主な市場プレーヤーとしては、Salix Pharmaceuticals、ALLERGAN、Lifecore Biomedical, LLC、Anika Therapeutics, Inc.、Smith &Nephew、マルハニチロ株式会社、Ferring B.V.、生化学工業株式会社、F. Hoffmann-La Roche Ltd.、Zimmer Biometなどが挙げられます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 ヒアルロン酸原材料市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
  • ヒアルロン酸原材料市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 ヒアルロン酸原材料：用途推定・動向分析

  • ヒアルロン酸原材料市場：重要なポイント
  • ヒアルロン酸原材料市場：動向と市場シェア分析、2022年および2030年
  • 眼科
  • 整形外科
  • 皮膚科
  • ドラッグデリバリー
  • 医療機器コーティング
  • 外科的癒着の予防
  • 生体材料とインプラント
  • 細胞および組織の保存

第5章 ヒアルロン酸原材料市場：原料推定・動向分析

  • ヒアルロン酸原材料市場：重要なポイント
  • ヒアルロン酸原材料市場：動向と市場シェア分析、2022年および2030年
  • 非動物
  • 動物

第6章 ヒアルロン酸原材料市場：グレードの推定・動向分析

  • ヒアルロン酸原材料市場：重要なポイント
  • ヒアルロン酸原材料市場：動向と市場シェア分析、2022年および2030年
  • 医薬品
  • 化粧品
  • 整形外科

第7章 ヒアルロン酸原材料市場：地域別の推定・動向分析

  • 地域別の展望
  • 地域別のヒアルロン酸原材料市場：重要なポイント
  • 北米
    • 市場推計・予測、2018～2030年
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 市場参入企業の分類
    • AbbVie Inc.
    • Salix Pharmaceuticals
    • Lifecore Biomedical, Inc.
    • Sanofi
    • Anika Therapeutics, Inc.
    • Zimmer Biomet
    • Smith+Nephew
    • LG Chem
    • Maruha Nichiro Corporation
    • Ferring B.V.
    • SEIKAGAKU CORPORATION
    • F. Hoffmann-La Roche Ltd.
図表

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America hyaluronic acid raw material market, by application, 2018 - 2030 (USD Million)
  • Table 3 North America hyaluronic acid raw material market, by source, 2018 - 2030 (USD Million)
  • Table 4 North America hyaluronic acid raw material market, by grade, 2018 - 2030 (USD Million)
  • Table 5 North America hyaluronic acid raw material market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. hyaluronic acid raw material market, by application, 2018 - 2030 (USD Million)
  • Table 7 U.S. hyaluronic acid raw material market, by source, 2018 - 2030 (USD Million)
  • Table 8 U.S. hyaluronic acid raw material market, by grade, 2018 - 2030 (USD Million)
  • Table 9 Canada hyaluronic acid raw material market, by application, 2018 - 2030 (USD Million)
  • Table 10 Canada hyaluronic acid raw material market, by source, 2018 - 2030 (USD Million)
  • Table 11 Canada hyaluronic acid raw material market, by grade, 2018 - 2030 (USD Million)
  • Table 12 Europe hyaluronic acid raw material market, by application, 2018 - 2030 (USD Million)
  • Table 13 Europe hyaluronic acid raw material market, by source, 2018 - 2030 (USD Million)
  • Table 14 Europe hyaluronic acid raw material market, by grade, 2018 - 2030 (USD Million)
  • Table 15 Europe hyaluronic acid raw material market, by region, 2018 - 2030 (USD Million)
  • Table 16 Germany hyaluronic acid raw material market, by application, 2018 - 2030 (USD Million)
  • Table 17 Germany hyaluronic acid raw material market, by source, 2018 - 2030 (USD Million)
  • Table 18 Germany hyaluronic acid raw material market, by grade, 2018 - 2030 (USD Million)
  • Table 19 UK hyaluronic acid raw material market, by application, 2018 - 2030 (USD Million)
  • Table 20 UK hyaluronic acid raw material market, by source, 2018 - 2030 (USD Million)
  • Table 21 UK hyaluronic acid raw material market, by grade, 2018 - 2030 (USD Million)
  • Table 22 France hyaluronic acid raw material market, by application, 2018 - 2030 (USD Million)
  • Table 23 France hyaluronic acid raw material market, by source, 2018 - 2030 (USD Million)
  • Table 24 France hyaluronic acid raw material market, by grade, 2018 - 2030 (USD Million)
  • Table 25 Italy hyaluronic acid raw material market, by application, 2018 - 2030 (USD Million)
  • Table 26 Italy hyaluronic acid raw material market, by source, 2018 - 2030 (USD Million)
  • Table 27 Italy hyaluronic acid raw material market, by grade, 2018 - 2030 (USD Million)
  • Table 28 Spain hyaluronic acid raw material market, by application, 2018 - 2030 (USD Million)
  • Table 29 Spain hyaluronic acid raw material market, by source, 2018 - 2030 (USD Million)
  • Table 30 Spain hyaluronic acid raw material market, by grade, 2018 - 2030 (USD Million)
  • Table 31 Sweden hyaluronic acid raw material market, by application, 2018 - 2030 (USD Million)
  • Table 32 Sweden hyaluronic acid raw material market, by source, 2018 - 2030 (USD Million)
  • Table 33 Sweden hyaluronic acid raw material market, by grade, 2018 - 2030 (USD Million)
  • Table 34 Norway hyaluronic acid raw material market, by application, 2018 - 2030 (USD Million)
  • Table 35 Norway hyaluronic acid raw material market, by source, 2018 - 2030 (USD Million)
  • Table 36 Norway hyaluronic acid raw material market, by grade, 2018 - 2030 (USD Million)
  • Table 37 Denmark hyaluronic acid raw material market, by application, 2018 - 2030 (USD Million)
  • Table 38 Denmark hyaluronic acid raw material market, by source, 2018 - 2030 (USD Million)
  • Table 39 Denmark hyaluronic acid raw material market, by grade, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific hyaluronic acid raw material market, by application, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific hyaluronic acid raw material market, by source, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific hyaluronic acid raw material market, by grade, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific hyaluronic acid raw material market, by region, 2018 - 2030 (USD Million)
  • Table 44 Japan hyaluronic acid raw material market, by application, 2018 - 2030 (USD Million)
  • Table 45 Japan hyaluronic acid raw material market, by source, 2018 - 2030 (USD Million)
  • Table 46 Japan hyaluronic acid raw material market, by grade, 2018 - 2030 (USD Million)
  • Table 47 China hyaluronic acid raw material market, by application, 2018 - 2030 (USD Million)
  • Table 48 China hyaluronic acid raw material market, by source, 2018 - 2030 (USD Million)
  • Table 49 China hyaluronic acid raw material market, by grade, 2018 - 2030 (USD Million)
  • Table 50 India hyaluronic acid raw material market, by application, 2018 - 2030 (USD Million)
  • Table 51 India hyaluronic acid raw material market, by source, 2018 - 2030 (USD Million)
  • Table 52 India hyaluronic acid raw material market, by grade, 2018 - 2030 (USD Million)
  • Table 53 Australia hyaluronic acid raw material market, by application, 2018 - 2030 (USD Million)
  • Table 54 Australia hyaluronic acid raw material market, by source, 2018 - 2030 (USD Million)
  • Table 55 Australia hyaluronic acid raw material market, by grade, 2018 - 2030 (USD Million)
  • Table 56 Thailand hyaluronic acid raw material market, by application, 2018 - 2030 (USD Million)
  • Table 57 Thailand hyaluronic acid raw material market, by source, 2018 - 2030 (USD Million)
  • Table 58 Thailand hyaluronic acid raw material market, by grade, 2018 - 2030 (USD Million)
  • Table 59 South Korea hyaluronic acid raw material market, by application, 2018 - 2030 (USD Million)
  • Table 60 South Korea hyaluronic acid raw material market, by source, 2018 - 2030 (USD Million)
  • Table 61 South Korea hyaluronic acid raw material market, by grade, 2018 - 2030 (USD Million)
  • Table 62 Latin America hyaluronic acid raw material market, by application, 2018 - 2030 (USD Million)
  • Table 63 Latin America hyaluronic acid raw material market, by source, 2018 - 2030 (USD Million)
  • Table 64 Latin America hyaluronic acid raw material market, by grade, 2018 - 2030 (USD Million)
  • Table 65 Latin America hyaluronic acid raw material market, by region, 2018 - 2030 (USD Million)
  • Table 66 Brazil hyaluronic acid raw material market, by application, 2018 - 2030 (USD Million)
  • Table 67 Brazil hyaluronic acid raw material market, by source, 2018 - 2030 (USD Million)
  • Table 68 Brazil hyaluronic acid raw material market, by grade, 2018 - 2030 (USD Million)
  • Table 69 Mexico hyaluronic acid raw material market, by application, 2018 - 2030 (USD Million)
  • Table 70 Mexico hyaluronic acid raw material market, by source, 2018 - 2030 (USD Million)
  • Table 71 Mexico hyaluronic acid raw material market, by grade, 2018 - 2030 (USD Million)
  • Table 72 Argentina hyaluronic acid raw material market, by application, 2018 - 2030 (USD Million)
  • Table 73 Argentina hyaluronic acid raw material market, by source, 2018 - 2030 (USD Million)
  • Table 74 Argentina hyaluronic acid raw material market, by grade, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa hyaluronic acid raw material market, by application, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa hyaluronic acid raw material market, by source, 2018 - 2030 (USD Million)
  • Table 77 Middle East and Africa hyaluronic acid raw material market, by grade, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa hyaluronic acid raw material market, by region, 2018 - 2030 (USD Million)
  • Table 79 South Africa hyaluronic acid raw material market, by application, 2018 - 2030 (USD Million)
  • Table 80 South Africa hyaluronic acid raw material market, by source, 2018 - 2030 (USD Million)
  • Table 81 South Africa hyaluronic acid raw material market, by grade, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia hyaluronic acid raw material market, by application, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia hyaluronic acid raw material market, by source, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia hyaluronic acid raw material market, by grade, 2018 - 2030 (USD Million)
  • Table 85 UAE hyaluronic acid raw material market, by application, 2018 - 2030 (USD Million)
  • Table 86 UAE hyaluronic acid raw material market, by source, 2018 - 2030 (USD Million)
  • Table 87 UAE hyaluronic acid raw material market, by grade, 2018 - 2030 (USD Million)
  • Table 88 Kuwait hyaluronic acid raw material market, by application, 2018 - 2030 (USD Million)
  • Table 89 Kuwait hyaluronic acid raw material market, by source, 2018 - 2030 (USD Million)
  • Table 90 Kuwait hyaluronic acid raw material market, by grade, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Hyaluronic acid raw material: Market outlook
  • Fig. 9 Hyaluronic acid raw material: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Hyaluronic acid raw material market driver impact
  • Fig. 15 Hyaluronic acid raw material market restraint impact
  • Fig. 16 Hyaluronic acid raw material market strategic initiatives analysis
  • Fig. 17 Hyaluronic acid raw material market: Application movement analysis
  • Fig. 18 Hyaluronic acid raw material market: Application outlook and key takeaways
  • Fig. 19 Ophthalmology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Cataract surgery market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Aqueous eye drop market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Contact lens market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Orthopedics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Viscosupplements market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Bone regeneration market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Dermatology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Intradermal market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Dermal filler market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Wound healing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Drug delivery market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Medical device coating market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Surgical adhesion prevention market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Biomaterials and implants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Cell and tissue preservation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Hyaluronic acid raw material market: Source movement analysis
  • Fig. 36 Hyaluronic acid raw material market: Source outlook and key takeaways
  • Fig. 37 Non-animal market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Animal market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Hyaluronic acid raw material market: Grade movement analysis
  • Fig. 40 Hyaluronic acid raw material market: Grade outlook and key takeaways
  • Fig. 41 Pharmaceutical market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Cosmetic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Orthopedic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Global hyaluronic acid raw material market: Regional movement analysis
  • Fig. 45 Global hyaluronic acid raw material market: Regional outlook and key takeaways
  • Fig. 46 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-1-68038-431-4

Hyaluronic Acid Raw Material Market Growth & Trends:

The global hyaluronic acid raw material market size is expected to reach USD 10.8 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to expand at a CAGR of 6.5% from 2023 to 2030. The increasing use of hyaluronic acid in various medical applications, such as osteoarthritis, wound healing, postoperative adhesion, tympanic membrane repair, tumor diagnosis, fracture healing, and soft tissue repair is expected to fuel the market growth over the forecast period.

The orthopedics segment dominated the overall market in 2015 with the highest revenue generation. The increasing geriatric population base, rising incidence of osteoarthritis, and growing adoption of viscosupplements in the treatments contribute to the large market share of this segment. Furthermore, the drug delivery segment is projected to be the fastest growing over the forecast period with a significantly higher CAGR. The increasing R&D activities focusing on targeted drug delivery systems and growing usage of hyaluronic acid in anti-cancer drug delivery is expected to contribute to the market growth.

The increasing women population of age 35 to 65 years across the globe engenders a greater demand for anti-aging cosmetic and aesthetic treatments. Owing to the distinctive viscoelastic and moisturizing properties coupled with lower toxicity levels offered by hyaluronic acid-based products, the demand for this polymer in dermal fillers as well as in the treatment of vesicoureteral reflux is expected to experience growth. Thus, it is anticipated that the need for such products will serve as a high impact driver for the hyaluronic acid products over the forecast period. Based on the statistics of the International Society of Aesthetic Plastic Surgery in 2014, there were approximately 20 million cosmetic procedures performed globally, of which nearly 13.5% of the procedures were HA-based non-surgical procedures.

Some of the top countries recording a majority of the aesthetic treatments in 2014 were the U.S., Brazil, Japan, South Korea, Mexico, Germany, France, and Colombia. Medical tourism for cosmetic surgery in the U.S. plays a very important role in aiding the uptake of HA-based products and procedures, which is expected to drive the market in the coming few years.

Hyaluronic Acid Raw Material Market Report Highlights:

  • The orthopedics segment dominated the market in 2022 with the largest revenue share of 39.7% owing to the growing adoption of technologically advanced drugs coupled with the wide usage of hyaluronic acid in the treatment procedures of osteoarthritis.
  • The introduction of FDA-approved hyaluronic acid-based viscosupplements such as ORTHOVISC and MONOVISC is expected to boost usage over the next 8 years
  • Some of the key market players are Salix Pharmaceuticals; ALLERGAN; Lifecore Biomedical, LLC; Anika Therapeutics, Inc.; Smith & Nephew; Maruha Nichiro Corporation; Ferring B.V.; SEIKAGAKU CORPORATION; F. Hoffmann-La Roche Ltd., Zimmer Biomet; and others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Application
    • 1.1.2. Source
    • 1.1.3. Grade
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application outlook
    • 2.2.2. Source outlook
    • 2.2.3. Grade outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Hyaluronic Acid Raw Material Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Hyaluronic Acid Raw Material Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Hyaluronic Acid Raw Material: Application Estimates & Trend Analysis

  • 4.1. Hyaluronic Acid Raw Material Market: Key Takeaways
  • 4.2. Hyaluronic Acid Raw Material Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Ophthalmology
    • 4.3.1. Ophthalmology market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.2. Cataract surgery
      • 4.3.2.1. Cataract surgery market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.3. Aqueous eye drop
      • 4.3.3.1. Aqueous eye drop market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.4. Contact lens
      • 4.3.4.1. Contact lens market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Orthopedics
    • 4.4.1. Orthopedics market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Viscosupplements
      • 4.4.2.1. Viscosupplements market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Bone regeneration
      • 4.4.3.1. Bone regeneration market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Dermatology
    • 4.5.1. Dermatology market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.2. Intradermal
      • 4.5.2.1. Intradermal market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.3. Dermal filler
      • 4.5.3.1. Dermal filler market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.4. Wound healing
      • 4.5.4.1. Wound healing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Drug Delivery
    • 4.6.1. Drug delivery market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Medical Device Coating
    • 4.7.1. Medical device coating market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.8. Surgical Adhesion Prevention
    • 4.8.1. Surgical adhesion prevention market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.9. Biomaterials and Implants
    • 4.9.1. Biomaterials and implants market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.10. Cell and Tissue Preservation
    • 4.10.1. Cell and tissue preservation market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Hyaluronic Acid Raw Material Market: Source Estimates & Trend Analysis

  • 5.1. Hyaluronic Acid Raw Material Market: Key Takeaways
  • 5.2. Hyaluronic Acid Raw Material Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Non-Animal
    • 5.3.1. Non-Animal market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Animal
    • 5.4.1. Animal market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Hyaluronic Acid Raw Material Market: Grade Estimates & Trend Analysis

  • 6.1. Hyaluronic Acid Raw Material Market: Key Takeaways
  • 6.2. Hyaluronic Acid Raw Material Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Pharmaceutical
    • 6.3.1. Pharmaceutical market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Cosmetic
    • 6.4.1. Cosmetic market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Orthopedic
    • 6.5.1. Orthopedic market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Hyaluronic Acid Raw Material Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. Hyaluronic Acid Raw Material Market by Region: Key Takeaway
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. France
      • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. Sweden
      • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Norway
      • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. China
      • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. India
      • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Market Participant Categorization
    • 8.2.1. AbbVie Inc.
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Salix Pharmaceuticals
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Lifecore Biomedical, Inc.
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Sanofi
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Anika Therapeutics, Inc.
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Zimmer Biomet
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Smith+Nephew
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. LG Chem
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Maruha Nichiro Corporation
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Ferring B.V.
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives
    • 8.2.11. SEIKAGAKU CORPORATION
      • 8.2.11.1. Company overview
      • 8.2.11.2. Financial performance
      • 8.2.11.3. Product benchmarking
      • 8.2.11.4. Strategic initiatives
    • 8.2.12. F. Hoffmann-La Roche Ltd.
      • 8.2.12.1. Company overview
      • 8.2.12.2. Financial performance
      • 8.2.12.3. Product benchmarking
      • 8.2.12.4. Strategic initiatives